UPDATE : Sunday, April 5, 2020
상단여백
Pfizer, MSD put off reorganizing due to COVID-19 by Kim Yun-mi 2020-04-03 17:09
‘Early aspirin cut reduced bleeding in acute coronary syndrome patients’ by Kim Yun-mi 2020-04-02 15:08
Korea could lead global standard for infectious disease diagnosis by Kim Yun-mi 2020-03-30 16:03
[Feature] Medical societies shift to online conferences in light of COVID-19 by Kim Yun-mi 2020-03-30 14:30
2 drugmakers react differently to coronavirus pandemic by Kim Yun-mi 2020-03-26 13:36
라인
Price negotiations begin for breast cancer combo drugs by Kim Yun-mi 2020-03-25 16:25
‘Outbreak will stop when 60% of Koreans become immune to COVID-19’ by Kim Yun-mi 2020-03-24 16:19
Study begins to compare 2 treatments for mild COVID-19 patients by Kim Yun-mi 2020-03-24 13:35
Drug sales reps turning to digital promotions by Kim Yun-mi 2020-03-23 16:15
‘No evidence for hypertension drug’s harmful effect on COVID-19 patients’ by Kim Yun-mi 2020-03-18 16:48
라인
HIV combo drug Dovato scores local nod by Kim Yun-mi 2020-03-17 15:58
Medical group calls for reopening Gaeseong complex to make masks by Kim Yun-mi 2020-03-12 17:07
COVID-19 robs local cardiologists of chance to present inspiring research by Kim Yun-mi 2020-03-12 11:25
45 COVID-19 test kits waiting for approval by Kim Yun-mi 2020-03-11 14:12
AbbVie’s Skyrizi expected to rock local psoriasis treatment market by Kim Yun-mi 2020-03-11 11:29
라인
Astellas’ Xospata wins license for acute myeloid leukemia by Kim Yun-mi 2020-03-09 16:40
295 Koreans to get remdesivir to fight COVID-19 by Kim Yun-mi 2020-03-09 11:05
Takeda begins developing COVID-19 plasma therapy TAK-888 by Kim Yun-mi 2020-03-06 14:35
Smart patient monitoring system installed at KUMC’s coronavirus facility  by Kim Yun-mi 2020-03-05 15:46
Korea nods testing remdesivir in COVID-19 patients by Kim Yun-mi 2020-03-04 13:46
여백
여백
여백
여백
Back to Top